From April 1, 2025, new anti-profiteering investigations under GST will cease, allowing businesses to set prices independently. Ongoing cases will continue, with the GST Appellate Tribunal taking over from the Competition Commission of India starting October 1, 2024.
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,